TrialX, in collaboration with investigators at the University of Iowa is proud to announce that the SAYSTOP Study App, developed to study antibiotic resistance using our remote data collection solution, has successfully completed enrollment. The “Study of…
The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells controlling voluntary muscle movement. Each year, more than 5,000 people in the United States are diagnosed, and around 30,000 people are living…
Clinical Research Coordinators (CRCs) are often the first point of contact for participants, guiding them through every step of a study. From screening to consent management and recruitment to protocol compliance, CRCs handle a broad and…
Making clinical trials more diverse isn’t just the right thing to do — it’s essential for developing treatments that work for everyone. Yet, despite FDA guidance, many trials still fail to reflect the real-world diversity of…
In the year 2000, ClinicalTrials.gov was launched with just 1,255 clinical trials listed. Fast-forward to today, and that number has grown to over 520,000, reflecting not only the acceleration of biomedical research but also the growing…
What’s New at TrialX! 🚀 Congratulations to the Reflections Collective Team! They won the Fierce DEI Awards in the Community Engagement and Outreach category, announced at the Patients as Partners Europe conference in London this month. True to its name,…
